The goals and the objectives of the AVEED REMS are to mitigate the negative outcomes associated with AVEED-induced pulmonary oil microembolism (POME) and anaphylaxis by:
Ensuring that AVEED is dispensed only in certified healthcare settings that have immediate access on-site to equipment and personnel trained to manage POME and anaphylaxis;
Informing healthcare providers that AVEED can cause POME and anaphylaxis, which have the potential to lead to serious medical consequences (e.g., respiratory distress and syncope);
Informing healthcare providers about the safe use of AVEED, including proper administration technique and patient observation; and
Informing patients about the risks of POME and anaphylaxis associated with AVEED and the importance of remaining at the healthcare setting for 30 minutes after each injection.
What do participants need to know?
Below is a general overview of the REMS for all REMS participants (e.g., patients, pharmacies, and healthcare providers). See the application holder(s) REMS Website or the approved REMS materials for more information.
Review the following: Education Program for Healthcare Providers.
Successfully complete the Knowledge Assessment and submit it to the REMS Program.
Enroll in the REMS by completing the Healthcare Provider Enrollment Form and submitting it to the REMS Program.
Before treatment initiation (first dose)
Counsel the patient on the risks, including pulmonary oil embolism (POME) and anaphylaxis, and the need to remain at the healthcare setting for 30 minutes following each injection using the Patient Guide.
Provide the patient with a copy of Patient Guide.
During treatment, before each injection
Counsel the patient on the risks, including pulmonary oil embolism (POME) and anaphylaxis, and the need to remain at the healthcare setting for 30 minutes following each injection using Patient Guide. Provide a copy of the Patient Guide to patient.
Patients who are prescribed Aveed
Before treatment initiation
Receive counseling from the prescriber on the risks, including pulmonary oil microembolism (POME) and anaphylaxis, and the need to remain at the healthcare setting for 30 minutes following each injection using Patient Guide.
Before administering
Receive counseling on risks, including POME and anaphylaxis, and the need to remain at the healthcare setting for 30 minutes following each injection from the prescriber using Patient Guide
After administration, for 30 minutes
Be monitored for pulmonary oil embolism (POME) or anaphylaxis by remaining at the healthcare setting after the injection.
Healthcare settings that dispense Aveed must
To become certified to dispense
Have immediate access to the necessary equipment and personnel to manage POME and anaphylaxis on-site.
Designate an authorized representative to carry out the certification process and oversee implementation and compliance with the REMS Program on behalf of the healthcare setting.
Have the authorized representative review the Education Program for Healthcare Settings.
Have the authorized representative enroll in the REMS Program by completing the Healthcare Settings Enrollment Form and submitting it to the REMS Program.
Train all relevant staff involved in dispensing Aveed using the Education Program for Healthcare Settings.
Establish processes and procedures to verify that all healthcare providers at the healthcare setting who prescribe Aveed are certified prior to prescribing Aveed, each patient is counseled before administration of the drug, and each patient is observed within the healthcare setting for 30 minutes following each injection.
Before dispensing
Verify the prescriber is certified.
Before adminstering
Counsel the patient on the risk of POME and anaphylaxis. Provide the patient with a copy of the Patient Guide.
After administering, for 30 minutes
Assess the patient for POME and anaphylaxis.
To maintain certification to dispense
Have a new authorized representative enroll in the REMS Program by completing the Healthcare Settings Enrollment Form if the authorized representative changes.
To maintain certification to dispense, every 2 years
Have authorized representative review the Education Program for Healthcare Settings.
Have the authorized representative re-enroll in the REMS Program by completing the Healthcare Settings Enrollment Form
At all times
Not distribute, transfer, loan, or sell Aveed, except to certified dispensers with the same authorized representative.
Maintain records of staff training and certified prescribers.
Comply with audits carried out by Endo Pharmaceuticals, Inc. to ensure that all processes and procedures are in place and are being followed.
Wholesalers-distributors that distribute Aveed must
To be able to distribute
Establish processes and procedures to ensure that the drug is distributed only to certified healthcare settings that have one or more certified prescribers associated with that address.
At all times
Distribute only to certified healthcare settings that have one or more certified prescribers associated with that address.
Maintain records of all shipments of Aveed.
What materials are included in the REMS?
The REMS includes a REMS Document. In addition, the REMS includes the following materials intended for patients and healthcare providers. For a specific Medication Guide of a product in the Aveed REMS, see the DailyMed link(s).
Modified to revise the Aveed REMS enrollment website content that appears on the healthcare provider (HCP)
enrollment screen.
09/01/2018
Modified to include a new REMS document and updated appended materials and REMS supporting document.
12/09/2016
Modified to establish a single shared system REMS for the elements to assure safe use required for the reference listed drug (RLD) Aveed and ANDAs referencing Aveed, called the Testosterone Undecanoate REMS Program, which will become applicable on the date of full approval of the first ANDA referencing Aveed.
03/05/2014
Approval of the REMS.
Disclaimer: This webpage provides general information about REMS programs
to various REMS participants (e.g., patients, pharmacies, and healthcare providers).
The summary information provided herein is not comprehensive and may not include
all of the information relevant to REMS participants. This webpage does not
constitute a replacement, modification, or revision of the approved REMS document,
including any appended REMS materials. Refer to the approved REMS document
for complete information on the REMS requirements for each approved application.